Compare COLL & PAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COLL | PAR |
|---|---|---|
| Founded | 2002 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2015 | N/A |
| Metric | COLL | PAR |
|---|---|---|
| Price | $48.66 | $37.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $47.50 | ★ $64.00 |
| AVG Volume (30 Days) | ★ 494.7K | 490.8K |
| Earning Date | 02-26-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | ★ $757,067,000.00 | $440,451,000.00 |
| Revenue This Year | $26.35 | $30.40 |
| Revenue Next Year | $3.67 | $12.01 |
| P/E Ratio | $29.06 | ★ N/A |
| Revenue Growth | 26.34 | ★ 39.88 |
| 52 Week Low | $23.23 | $31.65 |
| 52 Week High | $50.79 | $77.55 |
| Indicator | COLL | PAR |
|---|---|---|
| Relative Strength Index (RSI) | 58.37 | 54.13 |
| Support Level | $44.51 | $34.10 |
| Resistance Level | $50.79 | $36.84 |
| Average True Range (ATR) | 1.45 | 1.25 |
| MACD | -0.40 | -0.10 |
| Stochastic Oscillator | 63.89 | 64.93 |
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.